Alkion BioInnovations is pioneering the next-gen active ingredient bioproduction platform for the development and large-scale supply of critical vaccines and treatments.
-95%
Carbon footprint
-98%
Water
-95%
Space
-85%
Variability
0
Pesticide
95%
Automatisation
-75% to -99%
Production costs
What we do
Alkion innovates in plant tissue technologies. We have invented a process of biostimulation of plant genes in bioreactors to improve the production of molecules of interest in specific organs, with yields up to 800x compared to greenhouse culture. From the 1L lab reactor to our 300L “Alkaburst 2.0”, we are building the most efficient vertical & molecular farming system in the world for the production of high value active compounds. Alkion owns 4 patent families and exclusive licenses covering our breakthrough processes and technologies.
Our commitments
Sustainability is our priority
We are developing the most sustainable botanical platform. Through a carbon neutral approach, our closed-circuit technology saves energy, water, space* and recycles 95% of waste. We are committed to providing access to the most potent molecules for vaccine development to fight infectious diseases with worldwide organisations.
*compared to other state-of-the-art methods.
The highest quality
Our technology allows us to work with the purest biomass, with no use of pesticides or any other adulterants, making our extractions and purifications cleaner and greener.
Consistency
Thanks to our micropropagation process and strictly controlled culture conditions, we can guarantee a variability under 5% batch-to-batch consistently all year round for safety of patients and consumers.
Low cost
With Alkion’s technology, highest quality finally becomes affordable. With productivity increases orders of magnitude above current best practices, we can offer access to rare and expensive plant compounds for industrial use.
Security of production
Our method of plant culture in confined bioreactors with optimal utilisation of 3D space offers a security level commensurate with the production of sensitive compounds for medical purposes.